Revisiting the IGF-1R as a breast cancer target

Abstract The type I insulin-like growth factor-1 receptor is a well-described target in breast cancer and multiple clinical trials examining insulin-like growth factor-1 receptor have been completed. Unfortunately, monoclonal antibodies and tyrosine kinase inhibitors targeting insulin-like growth fa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roudy Chiminch Ekyalongo, Douglas Yee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/ff753cb1f1364c4681fe4a6c2ca7b956
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares